BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of the two-year results for the SENTRY trial, at the Vascular Interventional Advances ...
Please provide your email address to receive an email when new articles are posted on . Early results suggest that retrievable inferior vena cava filters can be removed with a more than 85% rate of ...
The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...
Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...
A 41-year-old man presented to the emergency department with back pain and bilateral peripheral edema. His medical history included antiphospholipid antibody syndrome. Seven years earlier, he had a ...
Unsealed court documents from lawsuits over inferior vena cava (IVC) filters expose a big gap between what manufacturers and regulators know about the safety of a medical device and how much of that ...
An inferior vena cava (IVC) filter is used to prevent life threatening pulmonary emboli. Once installed, the filter’s arms and legs open and anchors it to the walls of the IVC. The filter then catches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback